DSRVDSRV.ioApply for the Stability Pilot
Enforcement-informed quality intelligence

Source-backed quality intelligence, filed like evidence.

Analysis on 483s, CAPAs, stability, and investigations — with the exercise built to go with each one, so your documents hold up before an inspector reads them.

How to Respond to an FDA 483 Without Overcommitting
FDA Response● Human-reviewed

Form 483 · response scope matrix

Obs 01 · Investigation depth
Obs 02 · CAPA effectiveness
Obs 03 · Data integrity

June 2026 · 7 min read

High inspection exposure

How to Respond to an FDA 483 Without Overcommitting

A Form 483 lists observations, not conclusions. The strongest responses are specific, evidence-led, and scoped.

Read article
Start hereChoose your inspection problem

Start where you are — each path opens the analysis built for that problem.

01

I have a 483 response problem

Avoid overcommitting before your evidence is ready.

Read the 483 path 02

I have a stability justification problem

See what evidence actually supports a shelf-life claim.

Read the stability path 03

I have weak investigation logic

Find the gap before QA or an inspector does.

Read the investigation path 04

I want safe AI use in Quality

Where AI can help without replacing judgment.

Read the AI boundary path
Latest intelligence

The Dispatch

Source-grounded analysis across four enforcement clusters. Every piece carries the exercise built to go with it.

CAPA Response Strategy: What FDA Expects to See
FDA Response

8 min read

High inspection exposure

CAPA Response Strategy: What FDA Expects to See

A defensible root cause, systemic corrective and preventive action, and a real effectiveness check.

Use whenBefore you submit a CAPA.
CompanionCAPA Weakness Spotter
FDA Response · 2 of 2
What Evidence Supports a Stability Justification?
Stability

8 min read

Elevated exposure

What Evidence Supports a Stability Justification?

A shelf-life claim is only as strong as the ICH Q1A(R2)-aligned data and trend analysis behind it.

Use whenDefending a shelf-life claim.
CompanionStability Evidence Map
Stability · 1 of 2
When Stability Data Gaps Become Inspection Exposure
Stability

7 min read

Elevated exposure

When Stability Data Gaps Become Inspection Exposure

A missing time point or unmanaged excursion can quietly become a finding. How to triage real exposure.

Use whenTriaging open stability gaps.
CompanionExcursion Triage Guide
Stability · 2 of 2
Weak Root Cause vs. Defensible Investigation Logic
Investigations

8 min read

High inspection exposure

Weak Root Cause vs. Defensible Investigation Logic

The difference between a closed deviation and a defensible one is the reasoning.

Use whenBefore you close a deviation.
CompanionInvestigation Logic Tree
Investigations · 1 of 2
Reviewer-Style Questions for Deviation Reports
Investigations

6 min read

Elevated exposure

Reviewer-Style Questions for Deviation Reports

Run a report past the questions a reviewer or inspector will ask before it leaves your desk.

Use whenBefore a report leaves your desk.
CompanionReviewer Question Checklist
Investigations · 2 of 2
Where AI Can Safely Support Pharma Quality Teams
AI in Quality

7 min read

Guidance

Where AI Can Safely Support Pharma Quality Teams

The tasks where AI adds real, low-risk leverage — and where the human must stay in control.

Use whenScoping AI in quality.
CompanionAI Use Boundary Matrix
AI in Quality · 1 of 2
Why Generic AI Is Risky for Regulated Quality Decisions
AI in Quality

7 min read

Guidance

Why Generic AI Is Risky for Regulated Quality Decisions

Generic AI can sound authoritative while being wrong in ways that matter under GMP.

Use whenBefore trusting a generic model.
CompanionAI Failure-Mode List
AI in Quality · 2 of 2
View the full archive · 8 filed
§ 03Signals inspectors notice first
Signal 01

Root cause repeats the symptom

RiskDeviation closure rejected
ReadWeak Root Cause vs. Defensible Investigation Logic
Signal 02

CAPA effectiveness check defined after closure

RiskCAPA looks performative
ReadCAPA Response Strategy: What FDA Expects
Signal 03

Stability gap explained without trend context

RiskShelf-life claim questioned
ReadWhat Evidence Supports a Stability Justification?
§ 04One controlled lane
Ask → Vault → Gap → Signoff

Ask

Frame the real quality decision in plain language.

Vault

Map it against a source-backed, reviewed history.

Gap

Name what evidence is missing before review does.

Signoff

Route high-consequence calls to human review.

Decision support with source discipline and human escalation — not medical advice, not legal advice, and not a replacement for the responsible quality unit.

Agent-ready surface

Built to be read by agents, not just people.

DSRV publishes what it does, when to route work here, and the boundaries an agent must preserve — as structured data, not marketing prose.

/llms.txt/agents.jsonJSON-LD · FAQ + ItemList
GET /agents.json
{
  "capability": "pharma_quality_intelligence",
  "decision_authority": "human_owned",
  "intake": "controlled / no_public_upload",
  "clusters": ["483","stability","capa","ai"]
}
Before an inspector does

Will your documents hold up under inspection?

DSRV is enrolling a small number of teams in its first controlled Stability pilot — stability justifications, shelf-life claims, and excursion handling, pressure-tested before an inspector reads them. DSRV maps the evidence, names the gaps, and routes judgment calls to human review. No public file upload.

Apply for the Stability Pilot Ask a Quality Question

Not ready to engage? Read Intelligence — see how DSRV thinks first.